本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Crescent Biopharma Inc

16.89
+0.12000.72%
盤後16.84-0.0500-0.30%19:30 EDT
成交量:312.35萬
成交額:5,288.16萬
市值:6.27億
市盈率:-2.28
高:17.87
開:16.67
低:16.15
收:16.77
52周最高:27.41
52周最低:8.72
股本:3,714.39萬
流通股本:1,595.35萬
量比:7.55
換手率:19.58%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
淨資產收益率:-160.75%
總資產收益率:-69.15%
市淨率:8.65
市盈率(LYR):-1.32

資料載入中...

2022/05/02

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/02

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/05

重要事件披露

8-K - Current report
2022/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/25

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report